Published By : 07 Mar 2016 | Published By : QYRESEARCH
The World Health Organization’s guidelines on postpartum hemorrhaging, titled “WHO Recommendations for the Prevention and Treatment of Postpartum Hemorrhage,” can be taken as an alert of sorts by regions that are experiencing a high prevalence of PPH. If a woman loses more than 500 ml of blood within 24 hours of delivery, then she is taken in for treatment of PPH stage one. Lack of treatment at this stage can greatly complicate things and lead to severe symptoms as well as death. The WHO report states, in agreement to other studies on PPH, that it is the leading cause of maternal deaths in the world. A large number of these deaths could even have been avoided with precautionary care, such as the use of prophylactics during labor in stage three.
Healthcare Industry Attempts to Educate Masses on PPH
Again, as per the WHO guidelines, one of the greatest causes of PPH is sheer lack of knowledge. Not only are PPH cases in developing economies often misdiagnosed, but there is also a low rate of awareness of the utility of prophylactic uterotonics in its prevention. Even in cases where oxytocin is unavailable, there are alternative prophylactics which can be administered safely to prevent PPH. There is even the optional procedure of controlled cord traction, as new evidence had surfaced recently over its advantages.
The global market for treatment and medical devices for postpartum hemorrhage is therefore on the verge of experiencing a higher growth rate. Healthcare industries along with governments in developing economies are showing a higher rate of activity in educating people regarding this birth complication, allowing more people to opt for safer delivery options and reduce the risk of PPH. Additionally, new research can also help bring down the PPH cases around the world. For instance, a team of scientists had recently derived a conclusive link between the use of antidepressants and PPH. They found out that women taking SNRIs during the last month of pregnancy were more likely to generate the complication of PPH after childbirth, than women who did not consumer antidepressants.